RecruitingPhase 1 / Phase 2NCT06189963
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Sponsor: NKGen Biotech, Inc.
Glendale, CA · Santa Ana, CA · Tarzana, CA · +4 more sites
Phase 1/2 Alzheimer's Disease clinical trials
14 recruiting Phase 1/2 alzheimer's disease studies in the US. What trial phases mean
Other phases
RecruitingPhase 1 / Phase 2NCT07651319
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
Sponsor: The Methodist Hospital Research Institute
Houston, TX
RecruitingPhase 1 / Phase 2NCT07599670
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Sponsor: AbbVie
Irvine, CA · Boulder, CO · Bradenton, FL · +8 more sites
RecruitingPhase 1 / Phase 2NCT06597942
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
Sponsor: University of California, Los Angeles
Los Angeles, CA
RecruitingPhase 1 / Phase 2NCT07693140
Low-Dose Radiotherapy for Alzheimer's Disease
Sponsor: Evan Thomas
Winter Park, FL
RecruitingPhase 1 / Phase 2NCT06775964
Stem Cell Therapy for Early Alzheimer's Disease
Sponsor: Paul E Schulz
Houston, TX
RecruitingPhase 1 / Phase 2NCT06718686
Rifaximin SSD in Dementia Trial
Sponsor: Jasmohan Bajaj
Richmond, VA
RecruitingPhase 1 / Phase 2NCT06582706
Nicotinic Acid for the Treatment of Alzheimer's Disease
Sponsor: Indiana University
Indianapolis, IN
RecruitingPhase 1 / Phase 2NCT02649985
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
Sponsor: Brigham and Women's Hospital
Boston, MA
RecruitingPhase 1 / Phase 2NCT05336695
Assess Fibrin in Brains With AD/ADRD
Sponsor: Massachusetts General Hospital
Boston, MA
RecruitingPhase 1 / Phase 2NCT05395624
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Sponsor: Ashvattha Therapeutics, Inc.
San Francisco, CA · Stanford, CA · Jacksonville, FL
RecruitingPhase 1 / Phase 2NCT05374278
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Sponsor: David Wilson
San Francisco, CA
Not yet recruitingPhase 1 / Phase 2NCT06432166
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
Sponsor: MTI Biotech Inc
Nashville, TN
Not yet recruitingPhase 1 / Phase 2NCT06682767
A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)
Sponsor: Cedars-Sinai Medical Center
Los Angeles, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.